Clinical assessment and management of liver fibrosis in non-alcoholic fatty liver disease
Published 2020 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Clinical assessment and management of liver fibrosis in non-alcoholic fatty liver disease
Authors
Keywords
-
Journal
WORLD JOURNAL OF GASTROENTEROLOGY
Volume 26, Issue 39, Pages 5919-5943
Publisher
Baishideng Publishing Group Inc.
Online
2020-10-21
DOI
10.3748/wjg.v26.i39.5919
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Dose‐dependent reduction in body weight with LIK066 treatment in Japanese patients with obesity
- (2020) Koutaro Yokote et al. DIABETES OBESITY & METABOLISM
- Serial transient elastography examinations to monitor patients with type 2 diabetes: A prospective cohort study
- (2020) Hye Won Lee et al. HEPATOLOGY
- Collagen biology and non‐invasive biomarkers of liver fibrosis
- (2020) Morten A. Karsdal et al. LIVER INTERNATIONAL
- Obstructive sleep apnea and liver injury in severely obese patients with nonalcoholic fatty liver disease
- (2020) Li Zhang et al. Sleep and Breathing
- The global, regional, and national burden of cirrhosis by cause in 195 countries and territories, 1990–2017: a systematic analysis for the Global Burden of Disease Study 2017
- (2020) Sadaf G Sepanlou et al. Lancet Gastroenterology & Hepatology
- FibroScan-AST (FAST) score for the non-invasive identification of patients with non-alcoholic steatohepatitis with significant activity and fibrosis: a prospective derivation and global validation study
- (2020) Philip N Newsome et al. Lancet Gastroenterology & Hepatology
- Licogliflozin, a Novel SGLT1 and 2 Inhibitor: Body Weight Effects in a Randomized Trial in Adults with Overweight or Obesity
- (2020) Harold E. Bays et al. Obesity
- Performance of Noninvasive Liver Fibrosis Scores in the Morbid Obese Patient, Same Scores but Different Thresholds
- (2020) Diego Meneses et al. OBESITY SURGERY
- 2020 International Society of Hypertension Global Hypertension Practice Guidelines
- (2020) Thomas Unger et al. HYPERTENSION
- The role of statins in the management of nonalcoholic fatty liver disease
- (2019) Michael Doumas et al. CURRENT PHARMACEUTICAL DESIGN
- Non-invasive fibrosis scoring systems can predict future metabolic complications and overall mortality in non-alcoholic fatty liver disease (NAFLD)
- (2019) Kristina Önnerhag et al. SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY
- Diagnostic value of MRI-PDFF for hepatic steatosis in patients with non-alcoholic fatty liver disease: a meta-analysis
- (2019) Jiulian Gu et al. EUROPEAN RADIOLOGY
- Prevalence and Risk Factors of Significant Fibrosis in Patients With Nonalcoholic Fatty Liver Without Steatohepatitis
- (2019) S. Pelusi et al. Clinical Gastroenterology and Hepatology
- Liver Stiffness Severity is Associated With Increased Cardiovascular Risk in Patients With Type 2 Diabetes
- (2019) Neeraj Mangla et al. Clinical Gastroenterology and Hepatology
- Serum cytokeratin-18 and its relation to liver fibrosis and steatosis diagnosed by FibroScan and controlled attenuation parameter in nonalcoholic fatty liver disease and hepatitis C virus patients
- (2019) Samar K. Darweesh et al. EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY
- Development and Validation of Hepamet Fibrosis Scoring System A Simple, Noninvasive Test to Identify Patients With Nonalcoholic Fatty Liver Disease With Advanced Fibrosis
- (2019) Javier Ampuero et al. Clinical Gastroenterology and Hepatology
- Role of Vitamin E for Nonalcoholic Steatohepatitis in Patients With Type 2 Diabetes: A Randomized Controlled Trial
- (2019) Fernando Bril et al. DIABETES CARE
- The Effectiveness of Mediterranean Diet in Nonalcoholic Fatty Liver Disease Clinical Course: An Intervention Study
- (2019) Andriana C. Kaliora et al. JOURNAL OF MEDICINAL FOOD
- Clinical utility of an increase in magnetic resonance elastography in predicting fibrosis progression in NAFLD
- (2019) Veeral H. Ajmera et al. HEPATOLOGY
- Non-obese histologically confirmed NASH patients with abnormal liver biochemistry have more advanced fibrosis
- (2019) Qianyi Wang et al. Hepatology International
- Automated computerized image analysis for the user-independent evaluation of disease severity in preclinical models of NAFLD/NASH
- (2019) Maxime De Rudder et al. LABORATORY INVESTIGATION
- Metformin in the prevention of hepatocellular carcinoma in diabetic patients: A systematic review
- (2019) Victor Cunha et al. Annals of Hepatology
- Accuracy of liver stiffness measurement and controlled attenuation parameter using FibroScan® M/XL probes to diagnose liver fibrosis and steatosis in patients with nonalcoholic fatty liver disease: a multicenter prospective study
- (2019) Satoshi Oeda et al. JOURNAL OF GASTROENTEROLOGY
- A randomized, double-blind, multicenter, phase 2b study to evaluate the safety and efficacy of a combination of tropifexor and cenicriviroc in patients with nonalcoholic steatohepatitis and liver fibrosis: Study design of the TANDEM trial
- (2019) Marcos Pedrosa et al. Contemporary Clinical Trials
- Obeticholic acid for the treatment of non-alcoholic steatohepatitis: interim analysis from a multicentre, randomised, placebo-controlled phase 3 trial
- (2019) Zobair M Younossi et al. LANCET
- Liver stiffness measurement predicts long‐term survival and complications in non‐alcoholic fatty liver disease
- (2019) Sarah Shili‐Masmoudi et al. LIVER INTERNATIONAL
- Prospective Study of the Impact of Liver Biopsy Core Size on Specimen Adequacy and Procedural Complications
- (2018) Mitchell E. Tublin et al. AMERICAN JOURNAL OF ROENTGENOLOGY
- Renin–angiotensin system inhibition ameliorates CCl4-induced liver fibrosis in mice through the inactivation of nuclear transcription factor kappa B
- (2018) Sameh Saber et al. CANADIAN JOURNAL OF PHYSIOLOGY AND PHARMACOLOGY
- Vibration-controlled Transient Elastography to Assess Fibrosis and Steatosis in Patients With Nonalcoholic Fatty Liver Disease
- (2018) Mohammad S. Siddiqui et al. Clinical Gastroenterology and Hepatology
- Statins: An Under-Appreciated Asset for the Prevention and the Treatment of NAFLD or NASH and the Related Cardiovascular Risk
- (2018) Vasilios G. Athyros et al. Current Vascular Pharmacology
- Nonalcoholic fatty liver disease and hypertension
- (2018) Dimitrios Oikonomou et al. EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY
- A randomized, placebo-controlled trial of cenicriviroc for treatment of nonalcoholic steatohepatitis with fibrosis
- (2018) Scott L. Friedman et al. HEPATOLOGY
- Additive effects of PNPLA3 and TM6SF2 on the histological severity of non-alcoholic fatty liver disease
- (2018) Bo Kyung Koo et al. JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY
- Non-invasive assessment of non-alcoholic fatty liver disease: Clinical prediction rules and blood-based biomarkers
- (2018) Eduardo Vilar-Gomez et al. JOURNAL OF HEPATOLOGY
- Genetics and epigenetics of NAFLD and NASH: Clinical impact
- (2018) Mohammed Eslam et al. JOURNAL OF HEPATOLOGY
- Weight loss after bariatric surgery in obese adolescents: a systematic review and meta-analysis
- (2018) Felipe E. Pedroso et al. Surgery for Obesity and Related Diseases
- Comparison of conventional sonographic signs and magnetic resonance imaging proton density fat fraction for assessment of hepatic steatosis
- (2018) Mimi Kim et al. Scientific Reports
- A potential link between polycystic ovary syndrome and non-alcoholic fatty liver disease: an update meta-analysis
- (2018) Jia Wu et al. Reproductive Health
- Principles of ultrasound elastography
- (2018) Arinc Ozturk et al. Abdominal Radiology
- Evaluation of the effects of dapagliflozin, an SGLT2 inhibitor, on hepatic steatosis and fibrosis by transient elastography in patients with type 2 diabetes and non-alcoholic fatty liver disease
- (2018) Masanori Shimizu et al. DIABETES OBESITY & METABOLISM
- Continuous Positive Airway Pressure Therapy on Nonalcoholic Fatty Liver Disease in Patients With Obstructive Sleep Apnea
- (2018) Donghee Kim et al. Journal of Clinical Sleep Medicine
- An Evaluation of the Collagen Fragments Related to Fibrogenesis and Fibrolysis in Nonalcoholic Steatohepatitis
- (2018) Yi Luo et al. Scientific Reports
- Factors Associated With Histologic Response in Adult Patients With Nonalcoholic Steatohepatitis
- (2018) Rohit Loomba et al. GASTROENTEROLOGY
- Vitamin E Improves Transplant-free Survival and Hepatic Decompensation among Patients with NASH and Advanced Fibrosis
- (2018) Eduardo Vilar-Gomez et al. HEPATOLOGY
- Exercise as an intervention for patients with end-stage liver disease
- (2018) Cameron T. Locklear et al. MEDICINE
- Long-Term Outcomes After Bariatric Surgery: a Systematic Review and Meta-analysis of Weight Loss at 10 or More Years for All Bariatric Procedures and a Single-Centre Review of 20-Year Outcomes After Adjustable Gastric Banding
- (2018) Paul E. O’Brien et al. OBESITY SURGERY
- Vitamin E: Emerging aspects and new directions
- (2017) Francesco Galli et al. FREE RADICAL BIOLOGY AND MEDICINE
- The ASK1 inhibitor selonsertib in patients with nonalcoholic steatohepatitis: A randomized, phase 2 trial
- (2017) Rohit Loomba et al. HEPATOLOGY
- Comparison of laboratory tests, ultrasound, or magnetic resonance elastography to detect fibrosis in patients with nonalcoholic fatty liver disease: A meta-analysis
- (2017) Guangqin Xiao et al. HEPATOLOGY
- The diagnosis and management of nonalcoholic fatty liver disease: Practice guidance from the American Association for the Study of Liver Diseases
- (2017) Naga Chalasani et al. HEPATOLOGY
- Increased risk of mortality by fibrosis stage in nonalcoholic fatty liver disease: Systematic review and meta-analysis
- (2017) Parambir S. Dulai et al. HEPATOLOGY
- External validation of the non-alcoholic fatty liver disease fibrosis score for assessing advanced fibrosis in Korean patients
- (2017) Dae Won Jun et al. JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY
- Sarcopenia is an independent risk factor for non-alcoholic steatohepatitis and significant fibrosis
- (2017) Bo Kyung Koo et al. JOURNAL OF HEPATOLOGY
- Individual patient data meta-analysis of controlled attenuation parameter (CAP) technology for assessing steatosis
- (2017) Thomas Karlas et al. JOURNAL OF HEPATOLOGY
- Fibrosis stage but not NASH predicts mortality and time to development of severe liver disease in biopsy-proven NAFLD
- (2017) Hannes Hagström et al. JOURNAL OF HEPATOLOGY
- Discovery of Tropifexor (LJN452), a Highly Potent Non-bile Acid FXR Agonist for the Treatment of Cholestatic Liver Diseases and Nonalcoholic Steatohepatitis (NASH)
- (2017) David C. Tully et al. JOURNAL OF MEDICINAL CHEMISTRY
- The Mediterranean dietary pattern as the diet of choice for non-alcoholic fatty liver disease: Evidence and plausible mechanisms
- (2017) Shira Zelber-Sagi et al. LIVER INTERNATIONAL
- Global burden of NAFLD and NASH: trends, predictions, risk factors and prevention
- (2017) Zobair Younossi et al. Nature Reviews Gastroenterology & Hepatology
- Bariatric Surgery versus Intensive Medical Therapy for Diabetes — 5-Year Outcomes
- (2017) Philip R. Schauer et al. NEW ENGLAND JOURNAL OF MEDICINE
- A prospective comparative assessment of the accuracy of the FibroScan in evaluating liver steatosis
- (2017) Baek Gyu Jun et al. PLoS One
- Prevalence of non-alcoholic fatty liver disease and risk factors for advanced fibrosis and mortality in the United States
- (2017) Michael H. Le et al. PLoS One
- High-Intensity Aerobic Exercise Improves Both Hepatic Fat Content and Stiffness in Sedentary Obese Men with Nonalcoholic Fatty Liver Disease
- (2017) Sechang Oh et al. Scientific Reports
- Sarcopenia is associated with severe liver fibrosis in patients with non-alcoholic fatty liver disease
- (2016) S. Petta et al. ALIMENTARY PHARMACOLOGY & THERAPEUTICS
- Long-Term Pioglitazone Treatment for Patients With Nonalcoholic Steatohepatitis and Prediabetes or Type 2 Diabetes Mellitus
- (2016) Kenneth Cusi et al. ANNALS OF INTERNAL MEDICINE
- Clinical Presentation and Patient Evaluation in Nonalcoholic Fatty Liver Disease
- (2016) Vaishali Patel et al. Clinics in Liver Disease
- Obeticholic Acid: First Global Approval
- (2016) A. Markham et al. DRUGS
- Elafibranor, an Agonist of the Peroxisome Proliferator−Activated Receptor−α and −δ, Induces Resolution of Nonalcoholic Steatohepatitis Without Fibrosis Worsening
- (2016) Vlad Ratziu et al. GASTROENTEROLOGY
- The MBOAT7-TMC4 Variant rs641738 Increases Risk of Nonalcoholic Fatty Liver Disease in Individuals of European Descent
- (2016) Rosellina Margherita Mancina et al. GASTROENTEROLOGY
- Magnetic Resonance Imaging More Accurately Classifies Steatosis and Fibrosis in Patients With Nonalcoholic Fatty Liver Disease Than Transient Elastography
- (2016) Kento Imajo et al. GASTROENTEROLOGY
- Relationships between Genetic Variations of PNPLA3, TM6SF2 and Histological Features of Nonalcoholic Fatty Liver Disease in Japan
- (2016) Norio Akuta et al. Gut and Liver
- Liver stiffness in nonalcoholic fatty liver disease: A comparison of supersonic shear imaging, FibroScan, and ARFI with liver biopsy
- (2016) Christophe Cassinotto et al. HEPATOLOGY
- Global epidemiology of nonalcoholic fatty liver disease-Meta-analytic assessment of prevalence, incidence, and outcomes
- (2016) Zobair M. Younossi et al. HEPATOLOGY
- Comparison of FIB-4 index, NAFLD fibrosis score and BARD score for prediction of advanced fibrosis in adult patients with non-alcoholic fatty liver disease: A meta-analysis study
- (2016) Wenjing Sun et al. HEPATOLOGY RESEARCH
- Diagnostic accuracy and prognostic significance of blood fibrosis tests and liver stiffness measurement by FibroScan in non-alcoholic fatty liver disease
- (2016) Jérôme Boursier et al. JOURNAL OF HEPATOLOGY
- EASL–EASD–EASO Clinical Practice Guidelines for the management of non-alcoholic fatty liver disease
- (2016) JOURNAL OF HEPATOLOGY
- MRI and MRE for non-invasive quantitative assessment of hepatic steatosis and fibrosis in NAFLD and NASH: Clinical trials to clinical practice
- (2016) Parambir S. Dulai et al. JOURNAL OF HEPATOLOGY
- Combined effects of thePNPLA3rs738409,TM6SF2rs58542926, andMBOAT7rs641738 variants on NAFLD severity: a multicenter biopsy-based study
- (2016) Marcin Krawczyk et al. JOURNAL OF LIPID RESEARCH
- Nonalcoholic fatty liver disease and obstructive sleep apnea
- (2016) Judith Aron-Wisnewsky et al. METABOLISM-CLINICAL AND EXPERIMENTAL
- The impact of obstructive sleep apnea on nonalcoholic fatty liver disease in patients with severe obesity
- (2016) Peter Benotti et al. Obesity
- A Randomized Controlled Trial of Continuous Positive Airway Pressure on Glucose Tolerance in Obese Patients with Obstructive Sleep Apnea
- (2016) Neus Salord et al. SLEEP
- Meta-analysis of all-cause and cardiovascular mortality in obstructive sleep apnea with or without continuous positive airway pressure treatment
- (2016) Yiqun Fu et al. Sleep and Breathing
- Liver Steatosis and Fibrosis in OSA patients After Long-term CPAP Treatment: A Preliminary Ultrasound Study
- (2016) Maria Buttacavoli et al. ULTRASOUND IN MEDICINE AND BIOLOGY
- Transient elastography (FibroScan®) with controlled attenuation parameter in the assessment of liver steatosis and fibrosis in patients with nonalcoholic fatty liver disease - Where do we stand?
- (2016) Ivana Mikolasevic et al. WORLD JOURNAL OF GASTROENTEROLOGY
- Effects of Moderate and Vigorous Exercise on Nonalcoholic Fatty Liver Disease
- (2016) Hui-Jie Zhang et al. JAMA Internal Medicine
- Changes in Hepatic Venous Pressure Gradient Induced by Physical Exercise in Cirrhosis: Results of a Pilot Randomized Open Clinical Trial
- (2016) Ricardo U Macías-Rodríguez et al. Clinical and Translational Gastroenterology
- A Randomized Controlled Trial of Continuous Positive Airway Pressure on Glucose Tolerance in Obese Patients with Obstructive Sleep Apnea
- (2016) Neus Salord et al. SLEEP
- The Impact of Liver Cell Injury on Health-Related Quality of Life in Patients with Chronic Liver Disease
- (2016) Yvonne Alt et al. PLoS One
- Antifibrotic Effects of the Dual CCR2/CCR5 Antagonist Cenicriviroc in Animal Models of Liver and Kidney Fibrosis
- (2016) Eric Lefebvre et al. PLoS One
- Renin-Angiotensin System Inhibitors, Type 2 Diabetes and Fibrosis Progression: An Observational Study in Patients with Nonalcoholic Fatty Liver Disease
- (2016) Serena Pelusi et al. PLoS One
- Comparative diagnostic accuracy of magnetic resonance elastography vs. eight clinical prediction rules for non-invasive diagnosis of advanced fibrosis in biopsy-proven non-alcoholic fatty liver disease: a prospective study
- (2015) J. Cui et al. ALIMENTARY PHARMACOLOGY & THERAPEUTICS
- Weight Loss Through Lifestyle Modification Significantly Reduces Features of Nonalcoholic Steatohepatitis
- (2015) Eduardo Vilar-Gomez et al. GASTROENTEROLOGY
- Liver Fibrosis, but No Other Histologic Features, Is Associated With Long-term Outcomes of Patients With Nonalcoholic Fatty Liver Disease
- (2015) Paul Angulo et al. GASTROENTEROLOGY
- Bariatric Surgery Reduces Features of Nonalcoholic Steatohepatitis in Morbidly Obese Patients
- (2015) Guillaume Lassailly et al. GASTROENTEROLOGY
- Genetic variation in transmembrane 6 superfamily member 2 and the risk of nonalcoholic fatty liver disease and histological disease severity
- (2015) Silvia Sookoian et al. HEPATOLOGY
- Evidence of NAFLD progression from steatosis to fibrosing-steatohepatitis using paired biopsies: Implications for prognosis and clinical management
- (2015) Stuart McPherson et al. JOURNAL OF HEPATOLOGY
- Farnesoid X nuclear receptor ligand obeticholic acid for non-cirrhotic, non-alcoholic steatohepatitis (FLINT): a multicentre, randomised, placebo-controlled trial
- (2015) Brent A Neuschwander-Tetri et al. LANCET
- Bariatric–metabolic surgery versus conventional medical treatment in obese patients with type 2 diabetes: 5 year follow-up of an open-label, single-centre, randomised controlled trial
- (2015) Geltrude Mingrone et al. LANCET
- Impact of effective versus sham continuous positive airway pressure on liver injury in obstructive sleep apnoea: Data from randomized trials
- (2015) Ingrid Jullian-Desayes et al. RESPIROLOGY
- Nonalcoholic fatty liver disease
- (2015) Elizabeth M. Brunt et al. Nature Reviews Disease Primers
- Roux-en-Y Gastric Bypass Versus Adjustable Gastric Banding to Reduce Nonalcoholic Fatty Liver Disease
- (2014) Robert Caiazzo et al. ANNALS OF SURGERY
- Total Body Weight Loss of ≥10 % Is Associated with Improved Hepatic Fibrosis in Patients with Nonalcoholic Steatohepatitis
- (2014) Lisa M. Glass et al. DIGESTIVE DISEASES AND SCIENCES
- The Comparative Efficacy and Safety of the Angiotensin Receptor Blockers in the Management of Hypertension and Other Cardiovascular Diseases
- (2014) Hazel Mae A. Abraham et al. DRUG SAFETY
- Magnetic resonance elastography predicts advanced fibrosis in patients with nonalcoholic fatty liver disease: A prospective study
- (2014) Rohit Loomba et al. HEPATOLOGY
- Controlled attenuation parameter for the detection of steatosis severity in chronic liver disease: A meta-analysis of diagnostic accuracy
- (2014) Ke-Qing Shi et al. JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY
- Renin-angiotensin system and fibrosis in non-alcoholic fatty liver disease
- (2014) George B Goh et al. LIVER INTERNATIONAL
- Magnetic Resonance Elastography of Liver
- (2014) Sudhakar Kundapur Venkatesh et al. Magnetic Resonance Imaging Clinics of North America
- Glucokinase Regulatory Protein Gene Polymorphism Affects Liver Fibrosis in Non-Alcoholic Fatty Liver Disease
- (2014) Salvatore Petta et al. PLoS One
- The Performance of Enhanced Liver Fibrosis (ELF) Test for the Staging of Liver Fibrosis: A Meta-Analysis
- (2014) Qingsong Xie et al. PLoS One
- TM6SF2 rs58542926 influences hepatic fibrosis progression in patients with non-alcoholic fatty liver disease
- (2014) Yang-Lin Liu et al. Nature Communications
- Systematic review with meta-analysis: non-invasive assessment of non-alcoholic fatty liver disease - the role of transient elastography and plasma cytokeratin-18 fragments
- (2013) R. Kwok et al. ALIMENTARY PHARMACOLOGY & THERAPEUTICS
- Efficacy and Safety of the Farnesoid X Receptor Agonist Obeticholic Acid in Patients With Type 2 Diabetes and Nonalcoholic Fatty Liver Disease
- (2013) Sunder Mudaliar et al. GASTROENTEROLOGY
- The Mediterranean diet improves hepatic steatosis and insulin sensitivity in individuals with non-alcoholic fatty liver disease
- (2013) Marno C. Ryan et al. JOURNAL OF HEPATOLOGY
- Limited value of plasma cytokeratin-18 as a biomarker for NASH and fibrosis in patients with non-alcoholic fatty liver disease
- (2013) Kenneth Cusi et al. JOURNAL OF HEPATOLOGY
- Meta-analysis: ARFI elastography versus transient elastography for the evaluation of liver fibrosis
- (2013) Simona Bota et al. LIVER INTERNATIONAL
- The BARD score and the NAFLD fibrosis score in the assessment of advanced liver fibrosis in nonalcoholic fatty liver disease
- (2013) Halina Cichoż-Lach et al. MEDICAL SCIENCE MONITOR
- Advanced Fibrosis in Nonalcoholic Fatty Liver Disease: Noninvasive Assessment with MR Elastography
- (2013) Donghee Kim et al. RADIOLOGY
- Acoustic radiation force impulse of the liver
- (2013) Mirko D’Onofrio WORLD JOURNAL OF GASTROENTEROLOGY
- Prospective histopathologic evaluation of lifestyle modification in nonalcoholic fatty liver disease: a randomized trial
- (2013) Carly Eckard et al. Therapeutic Advances in Gastroenterology
- Detection of non-alcoholic steatohepatitis in patients with morbid obesity before bariatric surgery: preliminary evaluation with acoustic radiation force impulse imaging
- (2012) F. Guzmán-Aroca et al. EUROPEAN RADIOLOGY
- Histopathological algorithm and scoring system for evaluation of liver lesions in morbidly obese patients
- (2012) Pierre Bedossa et al. HEPATOLOGY
- Determination of reliability criteria for liver stiffness evaluation by transient elastography
- (2012) Jérôme Boursier et al. HEPATOLOGY
- Effects of Dapagliflozin on Body Weight, Total Fat Mass, and Regional Adipose Tissue Distribution in Patients with Type 2 Diabetes Mellitus with Inadequate Glycemic Control on Metformin
- (2012) Jan Bolinder et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- Metformin for Liver Cancer Prevention in Patients with Type 2 Diabetes: A Systematic Review and Meta-Analysis
- (2012) Zhi-Jiang Zhang et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- Exercise and non-alcoholic fatty liver disease: A systematic review and meta-analysis
- (2012) Shelley E. Keating et al. JOURNAL OF HEPATOLOGY
- Nonalcoholic fatty liver disease is associated with blood pressure in hypertensive and nonhypertensive individuals from the general population with normal levels of alanine aminotransferase
- (2011) Alejandro López-Suárez et al. EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY
- Acoustic radiation force impulse-imaging and transient elastography for non-invasive assessment of liver fibrosis and steatosis in NAFLD
- (2011) Mireen Friedrich-Rust et al. EUROPEAN JOURNAL OF RADIOLOGY
- Effect of Vitamin E or Metformin for Treatment of Nonalcoholic Fatty Liver Disease in Children and Adolescents
- (2011) Joel E. Lavine JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Vitamin E and the Risk of Prostate Cancer
- (2011) Eric A. Klein et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Effect of Bariatric Surgery on Liver Fibrosis
- (2011) Myriam Moretto et al. OBESITY SURGERY
- Effects of interventions on intra- and interobserver agreement on interpretation of nonalcoholic fatty liver disease histology
- (2010) Samer Gawrieh et al. Annals of Diagnostic Pathology
- Comparison of NAFLD fibrosis score and BARD score in predicting fibrosis in nonalcoholic fatty liver disease
- (2010) Gabriela Ruffillo et al. JOURNAL OF HEPATOLOGY
- Pioglitazone, Vitamin E, or Placebo for Nonalcoholic Steatohepatitis
- (2010) Arun J. Sanyal et al. NEW ENGLAND JOURNAL OF MEDICINE
- Nonalcoholic Fatty Liver Disease: US-based Acoustic Radiation Force Impulse Elastography
- (2010) Masato Yoneda et al. RADIOLOGY
- Accuracy of ultrasound to identify chronic liver disease
- (2010) Richard Allan WORLD JOURNAL OF GASTROENTEROLOGY
- Shear wave velocity is a useful marker for managing nonalcoholic steatohepatitis
- (2010) Akihiko Osaki WORLD JOURNAL OF GASTROENTEROLOGY
- Comparison of Noninvasive Markers of Fibrosis in Patients With Nonalcoholic Fatty Liver Disease
- (2009) Amy G. Shah et al. Clinical Gastroenterology and Hepatology
- Sodium-glucose co-transporter-2 inhibitors: an emerging new class of oral antidiabetic drug
- (2009) Iskandar Idris et al. DIABETES OBESITY & METABOLISM
- Heritability of Nonalcoholic Fatty Liver Disease
- (2009) Jeffrey B. Schwimmer et al. GASTROENTEROLOGY
- Applicability of BARD score to Japanese patients with NAFLD
- (2009) H Fujii et al. GUT
- Randomized controlled trial testing the effects of weight loss on nonalcoholic steatohepatitis
- (2009) Kittichai Promrat et al. HEPATOLOGY
- Cytokeratin-18 fragment levels as noninvasive biomarkers for nonalcoholic steatohepatitis: A multicenter validation study
- (2009) Ariel E. Feldstein et al. HEPATOLOGY
- Metformin in patients with non-alcoholic fatty liver disease: A randomized, controlled trial
- (2009) John Willy Haukeland et al. SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY
- Acoustic radiation force imaging sonoelastography fornoninvasive staging of liver fbrosis
- (2009) Carmen Fierbinteanu-Braticevici et al. WORLD JOURNAL OF GASTROENTEROLOGY
- Randomized, Placebo-Controlled Trial of Pioglitazone in Nondiabetic Subjects With Nonalcoholic Steatohepatitis
- (2008) Guruprasad P. Aithal et al. GASTROENTEROLOGY
- Development and validation of a simple NAFLD clinical scoring system for identifying patients without advanced disease
- (2008) S A Harrison et al. GUT
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started